IDO1 Fluorogenic Inhibitor Screening Assay Kit -384

Catalog #
72047
$1,070 *
Size: 384 wells
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The IDO1 Fluorogenic Inhibitor Screening Assay Kit is designed to measure enzyme inhibition of indoleamine 2,3-dioxygenase 1 (IDO1). The IDO1 Fluorogenic Inhibitor Screening Assay Kit is simple to use and detects fluorescence at long wavelengths, which minimizes potential errors due to compound interference. In the assay, the inhibitor and enzyme are added to a sample containing L-Trp substrate. After a 1 hour incubation at room temperature, the fluorescence solution is added and incubated at 37°C for four hours. Activity is measured by reading sample fluorescence at λ=510 nm following excitation of the reaction product at λ=400 nm.

Synonyms
Indoleamine 2,3-dioxygenase 1, IDO, activity assay kit
Product Info
Storage and Usage
Citations
Assay Kit Format
Fluorogenic
Supplied As
The kit comes in a convenient format, with enough reaction solution and enzyme to perform a total of 400 reactions.
Format

 

Catalog
Number

Component

Amount

Storage

71182

IDO1 His-Tag

2 x 80 µg

-80°C












Avoid multiple freeze/ thaw cycles!

73009

IDO1 Fluorogenic Reaction Solution

3 x 10 ml

-80°C

73002

IDO1 Assay Buffer

5 ml

-80°C

 

Fluorescence Solution

10 ml

-80°C

 

Black 384 Well Assay-Plate

1

 

 

Plate Sealing Film

1

 

UniProt #
P14902
Background
L-tryptophan (L-Trp) is an essential amino acid necessary for protein synthesis in mammalian cells and the L-Trp to kynurenine (Kyn) pathway is firmly established as a key regulator of innate and adaptive immunity. Catabolism of L-Trp to Kyn maintains an immunosuppressive microenvironment by starving immune cells of L-Trp and releasing degradation products of L-Trp that have immunosuppressive functions. Indoleamine 2,3- dioxygenases (IDO1 & IDO2), two of the rate limiting enzymes in this pathway, are upregulated in many tumors, providing cancer cells with an avenue for immune evasion.
References

Seegers, N., et al. J. Biomol. Screen. 2014. 19(9):1266-74.

Application References:
1. Deep Learning Model Enables the Discovery of a Novel Immunotherapeutic Agent Regulating the Kynurenine Pathway (2021)